Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03912402
What this trial is testing

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Who this might be right for
Cervical CancerCervical Cancer MetastaticCervical Cancer Recurrent
Biocad 49
Testing effectiveness (Phase 2)Looking for participantsNCT07101744
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)First-line Treatment Failure Nasopharyngeal Carcinoma
Sun Yat-sen University 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193186
What this trial is testing

Anlotinib and Benmelstobart in DTC

Who this might be right for
Thyroid Cancer
Fudan University 23
Testing effectiveness (Phase 2)WithdrawnNCT05879484
What this trial is testing

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Who this might be right for
Sinonasal CancerSquamous Non-small Cell Lung CancerLung Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04800978
What this trial is testing

Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy

Who this might be right for
Cervical Cancer
Samsung Medical Center 37
Large-scale testing (Phase 3)WithdrawnNCT02446652
What this trial is testing

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
National Institute of Cancerología
Large-scale testing (Phase 3)Looking for participantsNCT07216703
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 1,023
Early research (Phase 1)UnknownNCT04508686
What this trial is testing

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)

Who this might be right for
Advanced Cervical Cancer
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00446446
What this trial is testing

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

Who this might be right for
CancerCarcinomaHead and Neck Cancer+6 more
Amgen 52
Large-scale testing (Phase 3)Not Yet RecruitingNCT07783321
What this trial is testing

Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02)

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sichuan Baili Pharmaceutical Co., Ltd. 404
Testing effectiveness (Phase 2)Study completedNCT05007613
What this trial is testing

Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerMetastatic CancerSquamous Cell Carcinoma
National Taiwan University Hospital 24
Not applicableStudy completedNCT06771674
What this trial is testing

Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Hookipa Biotech GmbH 662
Early research (Phase 1)Ended earlyNCT02817113
What this trial is testing

Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Orient Europharma Co., Ltd. 4
Large-scale testing (Phase 3)Ended earlyNCT01704690
What this trial is testing

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Peking University 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07331428
What this trial is testing

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

Who this might be right for
Nasopharyngeal CarcinomaLocal Recurrence
Fujian Cancer Hospital 25
Testing effectiveness (Phase 2)UnknownNCT02016287
What this trial is testing

Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell CancerElderly Patients
Shen Lin 50
Testing effectiveness (Phase 2)Study completedNCT01443065
What this trial is testing

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

Who this might be right for
Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach
UNICANCER 162
Testing effectiveness (Phase 2)Looking for participantsNCT06725368
What this trial is testing

Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Centre Paul Strauss 46
Testing effectiveness (Phase 2)Study completedNCT02861690
What this trial is testing

Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma

Who this might be right for
Esophageal Carcinoma
Sun Yat-sen University 72
Testing effectiveness (Phase 2)UnknownNCT05013697
What this trial is testing

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Who this might be right for
Esophageal Neoplasms
Henan Cancer Hospital 48
Next Page